IP Library Granted Patent US 7,101,994
Granted Patent B2
US 7,101,994 · App. 10/240,906 · Granted Sep 5, 2006

Process for preparing substituted benzimidazole compounds

Assignee: SmithKline Beecham Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,994
App. No.
10/240,906
Granted
Sep 5, 2006
Kind
B2
Abstract

The invention relates to new methods of preparing substituted benzimidazole compounds, such as 2-bromo-5,6-dichlorobenzimidazole, which are useful in the preparation of compounds having antiviral activity.

Claims (15)

1. A process for preparing a compound of formula VII:

wherein:

R is —NR 8 R 9 where R 8 and R 9 are each independently selected from the group consisting of H, C 1-6 alkyl, cyanoC 1-6 alkyl, hydroxyC 1-6 alkyl, haloC 1-6 alkyl, C 3-7 cycloalkyl, C 1-6 alkylC 3-7 cycloalkyl, C 2-6 alkenyl, C 3-7 cycloalkylC 1-6 alkyl, C 2-6 alkynyl, aryl, arylC 1-6 alkyl, and COC 1-6 alkyl; and

each R 10 is independently selected from the group consisting of hydroxy and protected hydroxy group;

or a pharmaceutically acceptable derivative or prodrug thereof;

said process comprising the steps of:

(a) cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole to yield a compound of formula II:

(b) reacting the compound of formula II with PO(X) 3 wherein X is halo, to prepare a compound of formula I:

(c) reacting the compound of formula I with a furanosyl of formula III:

 to prepare a compound of formula V:

(d) reacting the compound of formula V with an amine of formula H—NR 8 R 9 ;

to prepare a compound of formula VII or a pharmaceutically acceptable derivative or prodrug thereof.

2. The process according to claim 1 , wherein one or more of R 10 is protected hydroxy group and said process further comprises the step of removing any protecting groups.

3. The process according to claim 1 , wherein R is isopropylamino and the furanosyl moiety:

is β-L-ribofuranosyl.

Assignments (3)
CHANGE OF NAME Recorded Dec 26, 2017
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 044961/0930 →
MERGER Recorded Feb 11, 2003
From: GLAXO WELLCOME INC.
To: SMITHKLINE BEECHMAN CORPORATION
Reel/Frame 013742/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2003
From: FREEMAN, STEPHEN
To: GLAXO WELLCOME INC.
Reel/Frame 013742/0535 →
Priority Claims (1)
GB 0008939.1 · Apr 11, 2000 · national
Continuity (1)
Related Publication 20030191127A1 · Oct 9, 2003